Herspiegel Consulting

What Herspiegel Consulting does

Herspiegel Consulting is a Yardley, Pennsylvania-based pharmaceutical and biotech commercialization consultancy founded in 2007 by Brent Herspiegel. The firm provides integrated services across the full biopharma product lifecycle, organized into six practice areas: Launch Excellence, Market Access & HEOR, Medical Affairs, Patient Services, Marketing Excellence, and Contract Commercial Services. It serves both emerging biotech companies undertaking their first commercialization and the world's largest pharmaceutical companies, with a combined Acumetis workforce of 350+ experts across 15+ countries following the April 2026 unified brand launch. The firm is backed by private equity sponsor DFW Capital Partners, which provided a growth investment in October 2023 to fund a four-firm acquisition strategy (Sixsense Strategy Group, Adivo Associates, FIECON, Decisive Consulting) that has materially expanded its therapeutic-area coverage and geographic footprint.

The underlying technology stack centers on the proprietary Adivo data platform, which delivers 50% direct market capture across specialty and rare disease channels in up to 50 countries, tracking patient demographics, volumes, prices, and brand switches. Complementary proprietary tools include the AI-enabled PICO Predict for EU Joint Clinical Assessment scenario modeling, JCA Lab for end-to-end HTA readiness, the DTP Readiness Assessment, the MFN Exposure Assessment, and the Herspiegel Rapid Insights subscription service. The firm's methodology IP includes 100+ developed health economic models across 20+ countries and 40+ indications, and 30+ HTA submissions to NICE, SMC, and AWMSG.

Revenue is generated through fee-for-service professional consulting engagements — typically project-based or multi-year retainer arrangements — with bespoke pricing. The go-to-market motion is direct enterprise sales targeting pharmaceutical and biotech decision-makers, supported by a dedicated business development team (Head of BD, EVP BD, Directors of BD & Client Success), thought leadership content (white papers, case studies, Commercial Conversations video series), and presence at industry events such as MAPS America. The company holds SBTi-validated emissions targets and a Bronze EcoVadis Medal, and operates under GDPR-compliant data practices through its US parent entity HC Parent Corp.

Name

Herspiegel Consulting

Legal name

HC Parent Corp

Website

https://herspiegel.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1–10 employees

Short description

Herspiegel Consulting is a Yardley, PA-based pharmaceutical and biotech commercialization consultancy founded in 2007, now unified as Acumetis. The 350+ expert firm delivers launch excellence, market access, HEOR, medical affairs, and patient services to 150+ life sciences organizations globally.

Ownership category

akta.pro rank

Product category

Pharmaceutical Commercialization Consulting

NAICS

Management Consulting Services (54161), Administrative Management and General Management Consulting Services (541611)

SIC

Services-Management Consulting Services (8742), Services-Management Services (8741)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Data, Analytics & AI Consulting (BPAHACAI), Innovation, Product & R&D Consulting (BPAHACAM), Data, Analytics & AI Consulting (BPAHAEAF)

Keywords

• Pharmaceutical commercialization consulting
• Biotech launch excellence
• Market access strategy
• Medical affairs consulting
• Health economics outcomes research

Headquarters

HQ city

Yardley

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Professional Consulting Services: Herspiegel generates revenue through fee-for-service consulting engagements with pharmaceutical and biotech companies. Services span commercial strategy, market access, medical affairs, patient services, launch excellence, and contract commercial services. Engagements are typically project-based or retainer arrangements with clients ranging from biotech start-ups to large global pharmaceutical companies.

Pricing tiers

Go-to-market motion3 records

Distribution channels1 record

Marketing channels8 records

Core offering

Herspiegel Consulting is a full-service life sciences commercialization consultancy that guides pharmaceutical and biotech companies through their most decisive commercialization moments. The firm delivers integrated services spanning launch excellence, market access and HEOR, medical affairs, patient services, marketing excellence, and contract commercial services, supported by proprietary data and analytics platforms including the Adivo Platform.

Product overview

Herspiegel Consulting operates as a life sciences commercialization consultancy that has unified five specialist firms—Herspiegel, Adivo Associates, Decisive Consulting, Fiecon, and Sixsense Strategy Group—under the Acumetis brand. The company offers integrated services organized into practice areas including Launch Excellence, Medical Affairs (powered by Sixsense Strategy Group), Patient Services, Market Access and HEOR, Marketing Excellence, and Contract Commercial Services. These services are supported by proprietary technology platforms including the Adivo Platform for specialty data and analytics, Herspiegel Rapid Insights subscription service, and specialized assessment tools including DTP Readiness Assessment, PICO Predict (AI-enabled), JCA Lab, and MFN Exposure Assessment. The combined entity brings together 350+ experts serving 150+ life sciences organizations globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Launch Excellence Strategic consulting for pharmaceutical product launches, spanning strategy development, tactical planning, and seamless execution to de-risk and accelerate launches across 25+ therapeutic areas, with 150+ successful launches to date.
• Market Access and HEOR Market access strategy and health economics services including evidence-based value establishment, HTA submissions, economic modeling, pricing strategy, and reimbursement planning across 40+ countries, with 100+ health economic models developed.
• Medical Affairs Medical affairs services including medical strategy development, KOL engagement planning, and medical communications for teams launching new therapies or entering new disease states, powered by Sixsense Strategy Group.
• Patient Services Patient experience programs that remove barriers to access and improve adherence, including HUB and specialty pharmacy optimization, field reimbursement manager support, and patient support program design.
• Commercial Strategy (Marketing Excellence) Commercial strategy and brand management services guiding products through the entire lifecycle from new product launch to managing competitive entries and loss of exclusivity.
• Contract Commercial Services Ready-to-deploy commercialization team with experience from 125+ launches and proven go-to-market model. Provides scalable commercial leadership for launch and beyond with 100+ seasoned commercial leaders.
• Adivo Platform Proprietary specialty data and analytics platform that delivers insights for rare disease and specialty markets. Offers 50% direct capture across all channels and segments in up to 50 countries, tracking KPIs including patient demographics, volumes, prices, and brand switches.
• Herspiegel Rapid Insights Subscription service delivering tailored responses to questions about pharmaceutical industry benchmarks, trends, organizational structure, spending analysis, pricing, and regulatory impact.

Quantifiable outcome

• 150+ successful pharmaceutical product launches across primary care, oncology, rare diseases, and cell and gene therapy
• +5 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered key and core.

• BrandingBusinesskeyGTM or Marketing Partner · 14 April 2026BrandingBusiness, a B2B brand strategy firm, led the brand development for Acumetis, including name derivation from Greek words, corporate messaging framework, logo, and visual identity system with the tagline 'Reframe what's possible.' The firm created and launched the new global brand for the life sciences commercialization entity.
• Adivo AssociatescoreStrategic or Co-development Partner · 14 April 2026Adivo Associates, a specialty market data and analytics firm, merged with Herspiegel as part of the Acumetis formation. Adivo's proprietary data platform provides 50% direct capture across all channels and segments in up to 50 countries, enhancing the combined entity's insights and analytics capabilities.
• Decisive ConsultingcoreStrategic or Co-development Partner · 14 April 2026Decisive Consulting, a strategic consulting firm focused on market access and evidence strategy, merged with Herspiegel as part of the Acumetis formation. The combination strengthens global market access, HEOR, and go-to-market capabilities of the combined entity.
• FIECONcoreStrategic or Co-development Partner · 14 April 2026FIECON, a health economics and outcomes research consultancy, merged with Herspiegel as part of the Acumetis formation. FIECON brings expertise in economic modelling, HTA submissions, pricing and reimbursement strategy, and value communication, operating under fiecon.com.
• Sixsense Strategy GroupcoreStrategic or Co-development Partner · 14 April 2026Sixsense Strategy Group (SSG), a medical affairs strategy consultancy, merged with Herspiegel as part of the Acumetis formation. SSG's core strengths in Medical Strategy, KOL Engagement, and Medical Communications enhance the company's industry-leading launch capabilities in life sciences.

Scale indicators12 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• ZS Associates: ZS Associates is a leading pharmaceutical and biotech consulting firm that provides commercialization, sales, and marketing services. They are a direct competitor in pharmaceutical consulting with significantly larger scale.
• Syneos Health Consulting: Syneos Health offers pharmaceutical commercialization consulting services that directly overlap with Herspiegel's market access, medical affairs, and patient services offerings.
• Trinity Life Sciences: Trinity Life Sciences is a life sciences commercialization consulting firm that provides strategy, analytics, and insights for pharmaceutical and biotech clients, competing in a similar niche.
• Definitive Healthcare: Definitive Healthcare provides commercial intelligence and analytics for the life sciences industry, similar to Herspiegel's data-driven approach to pharmaceutical market insights.

Broad incumbents

• IQVIA: IQVIA is a major healthcare data and consulting firm that provides commercialization and market access services to pharmaceutical clients, representing a larger scaled competitor in the same domain.
• Bain & Company (Healthcare Practice): Bain & Company operates a substantial healthcare and life sciences practice that competes for similar pharmaceutical strategy and commercialization engagements. They are a broader incumbent with global scale.
• McKinsey & Company (Pharmaceutical Practice): McKinsey is a global management consulting firm with a large pharmaceutical and biotech practice. While much larger, they compete for strategic consulting engagements with similar life sciences clients.
• Parexel (Commercialization Services): Parexel provides biopharmaceutical services including commercialization and market access consulting, representing a broader incumbent competitor with global scale.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat5 records

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/herspiegel

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Herspiegel Consulting